For patients who have undergone surgery for high-risk skin cancer of the head and neck, this study aims to determine whether there is a difference in time to loco-regional relapse (cancer coming back in the same area) between patients treated with concurrent chemo-radiotherapy (using the chemo drug Carboplatin) versus those participants who were treated with radiotherapy alone.